Free Trial
NASDAQ:IMMP

Prima BioMed (IMMP) Stock Price, News & Analysis

Prima BioMed logo
$1.95 +0.09 (+4.84%)
Closing price 04:00 PM Eastern
Extended Trading
$1.94 -0.01 (-0.77%)
As of 06:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Prima BioMed Stock (NASDAQ:IMMP)

Advanced

Key Stats

Today's Range
$1.86
$1.99
50-Day Range
$1.60
$1.88
52-Week Range
$1.32
$2.71
Volume
186,357 shs
Average Volume
148,713 shs
Market Capitalization
$286.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00
Consensus Rating
Hold

Company Overview

Prima BioMed Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
21st Percentile Overall Score

IMMP MarketRank™: 

Prima BioMed scored higher than 21% of companies evaluated by MarketBeat, and ranked 846th out of 937 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Prima BioMed has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, no hold ratings, and 1 sell rating.

  • Upside Potential

    Prima BioMed has a consensus price target of $7.00, representing about 257.1% upside from its current price of $1.96.

  • Amount of Analyst Coverage

    Prima BioMed has only been the subject of 1 research reports in the past 90 days.

  • Read more about Prima BioMed's stock forecast and price target.
  • Earnings Growth

    Earnings for Prima BioMed are expected to decrease in the coming year, from ($0.40) to ($0.50) per share.

  • Price to Book Value per Share Ratio

    Prima BioMed has a P/B Ratio of 3.11. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    2.90% of the outstanding shares of Prima BioMed have been sold short.
  • Short Interest Ratio / Days to Cover

    Prima BioMed has a short interest ratio ("days to cover") of 53.9, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Prima BioMed has recently decreased by 0.70%, indicating that investor sentiment is improving.
  • Dividend Yield

    Prima BioMed does not currently pay a dividend.

  • Dividend Growth

    Prima BioMed does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.90% of the outstanding shares of Prima BioMed have been sold short.
  • Short Interest Ratio / Days to Cover

    Prima BioMed has a short interest ratio ("days to cover") of 53.9, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Prima BioMed has recently decreased by 0.70%, indicating that investor sentiment is improving.
  • Search Interest

    6 people have searched for IMMP on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • MarketBeat Follows

    4 people have added Prima BioMed to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Prima BioMed insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.07% of the stock of Prima BioMed is held by insiders.

  • Percentage Held by Institutions

    Only 2.32% of the stock of Prima BioMed is held by institutions.

  • Read more about Prima BioMed's insider trading history.
Receive IMMP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Prima BioMed and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IMMP Stock News Headlines

Immutep Quarterly Activities Report Q4 FY25
GOLD ALERT
Gold has shattered records, soaring past $3,800 an ounce... But Stansberry Senior Partner Dr. David "Doc" Eifrig says history shows it could be on the verge of its biggest bull run in over half a century.tc pixel
See More Headlines

IMMP Stock Analysis - Frequently Asked Questions

Prima BioMed's stock was trading at $2.17 on January 1st, 2025. Since then, IMMP stock has decreased by 9.7% and is now trading at $1.96.

Shares of IMMP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Prima BioMed investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), CymaBay Therapeutics (CBAY), Pfizer (PFE), Broadcom (AVGO) and GE Aerospace (GE).

Company Calendar

Today
10/06/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:IMMP
CIK
1506184
Employees
2,021
Year Founded
2001

Price Target and Rating

High Price Target
$7.00
Low Price Target
$7.00
Potential Upside/Downside
+259.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
11.69
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$6.69 million
Price / Sales
42.79
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.63 per share
Price / Book
3.10

Miscellaneous

Outstanding Shares
146,790,000
Free Float
142,280,000
Market Cap
$286.24 million
Optionable
Optionable
Beta
1.87

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:IMMP) was last updated on 10/6/2025 by MarketBeat.com Staff
From Our Partners